Lilly reports positive data for breast cancer drug
admin 25th April 2017 Uncategorised 0Eli Lilly is gearing up to file data for its experimental breast cancer drug abemaciclib after it was found to slow disease progression in a late-stage trial.
More: Lilly reports positive data for breast cancer drug
Source: News